Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,712,913
+$227,022 QoQ
Shares Held
6,807
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#2,092
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARATHON CAPITAL MANAGEMENT holds $31,900,311 across 10 Drug Manufacturers - General names. ABBV ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
64,777 | $12,283,014 | |
| 2 | JNJ |
Johnson & Johnson
|
25,121 | $6,379,980 | |
| 3 | NVO |
Novo Nordisk A S
|
78,134 | $3,745,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,351 | $3,000,603 | |
| 5 | LLY |
ELI LILLY & Co
|
2,492 | $2,988,979 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
6,807 | $1,712,913 | |
| 7 | AMGN |
Amgen Inc
|
2,533 | $917,249 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,325 | $479,686 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,712,913 | 6,807 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,485,891 | 6,832 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,589,604 | 6,957 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,453,839 | 6,279 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,165,507 | 6,279 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,326,680 | 6,332 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,129,638 | 6,357 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,265,254 | 6,407 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,101,501 | 6,422 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,132,115 | 6,217 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $971,196 | 6,267 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $967,697 | 6,492 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $894,876 | 6,642 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,069,372 | 6,710 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,729,516 | 29,265 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,948,323 | 29,419 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,532,923 | 29,596 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,778,192 | 29,475 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,023,681 | 29,717 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,226,931 | 29,915 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,363,993 | 29,865 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,245,517 | 29,990 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,070,919 | 28,660 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,394,272 | 27,335 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,779,573 | 28,311 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,067,491 | 27,136 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||